April 22, 2024
Bria defended her thesis: "CD28 signaling upregulates phosphoenolpyruvate carboxykinase-2 (PCK2) to maintain T cell metabolic fitness.”
Best of luck in clinical trials at Arkansas Children’s Research Hospital!
April 22, 2024
Bria defended her thesis: "CD28 signaling upregulates phosphoenolpyruvate carboxykinase-2 (PCK2) to maintain T cell metabolic fitness.”
Best of luck in clinical trials at Arkansas Children’s Research Hospital!
Mailing address:
Brian Koss, PhD
UAMS Biochemistry
4301 W. Markham, Slot 516
Little Rock, AR 72205-7199
501-526-8403